Key Points
- Director Mitchell Austin Rudy bought 9,000 Bonk shares for $10,890 at $1.21 each on July 13, increasing his direct stake to 95,000 shares valued at about $114,950.
- Rudy has been actively buying BNKK recently, with several additional purchases in June and July, including 12,000 shares on June 10 and 11,659 shares on July 2.
- Bonk shares rose 11.0% in the session, but the stock remains highly volatile, with a 52-week range of $1.14 to $46.90 and a consensus analyst rating of Sell.
Bonk, Inc. (NASDAQ:BNKK - Get Free Report) Director Mitchell Austin Rudy purchased 9,000 shares of the stock in a transaction dated Monday, July 13th. The stock was purchased at an average price of $1.21 per share, with a total value of $10,890.00. Following the completion of the acquisition, the director directly owned 95,000 shares in the company, valued at approximately $114,950. The trade was a 10.47% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Mitchell Austin Rudy also recently made the following trade(s):
- On Friday, July 10th, Mitchell Austin Rudy acquired 1,000 shares of Bonk stock. The shares were purchased at an average price of $1.21 per share, for a total transaction of $1,210.00.
- On Thursday, July 2nd, Mitchell Austin Rudy acquired 11,659 shares of Bonk stock. The stock was acquired at an average cost of $1.47 per share, with a total value of $17,138.73.
- On Monday, June 22nd, Mitchell Austin Rudy bought 7,500 shares of Bonk stock. The shares were acquired at an average price of $1.56 per share, with a total value of $11,700.00.
- On Tuesday, June 16th, Mitchell Austin Rudy purchased 2,500 shares of Bonk stock. The stock was acquired at an average price of $1.32 per share, for a total transaction of $3,300.00.
- On Wednesday, June 10th, Mitchell Austin Rudy purchased 12,000 shares of Bonk stock. The stock was acquired at an average cost of $1.37 per share, with a total value of $16,440.00.
Bonk Stock Up 11.0%
Shares of NASDAQ:BNKK opened at $1.31 on Wednesday. The company has a market cap of $10.48 million, a PE ratio of -0.28 and a beta of 1.89. Bonk, Inc. has a fifty-two week low of $1.14 and a fifty-two week high of $46.90. The firm has a 50-day simple moving average of $1.70 and a 200 day simple moving average of $2.70.
Bonk (NASDAQ:BNKK - Get Free Report) last issued its earnings results on Wednesday, May 13th. The company reported ($0.23) EPS for the quarter. The company had revenue of $0.79 million during the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%.
Institutional Investors Weigh In On Bonk
A number of hedge funds have recently made changes to their positions in BNKK. State Street Corp acquired a new position in shares of Bonk during the fourth quarter worth approximately $33,000. Steward Partners Investment Advisory LLC bought a new stake in Bonk during the 4th quarter valued at $37,000. Jane Street Group LLC bought a new stake in Bonk during the 4th quarter valued at $96,000. Finally, Geode Capital Management LLC acquired a new position in Bonk during the 4th quarter worth $128,000. Institutional investors own 12.55% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on BNKK shares. Wall Street Zen upgraded Bonk from a "sell" rating to a "hold" rating in a research note on Saturday, July 4th. Weiss Ratings downgraded shares of Bonk from a "sell (d-)" rating to a "sell (e+)" rating in a report on Wednesday, April 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of "Sell".
View Our Latest Stock Analysis on BNKK
Bonk Company Profile
(
Get Free Report)
Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
